Incidence, Associated Factors, and Burden of Post COVID-19 Condition in Brazil

Inova Medical

Status: Enrolling

Conditions: Post-Acute COVID-19 Syndrome

Treatments: Other: Multiple exposures

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT05822193

2023/001

Details and patient eligibility

About

This is a national retrospective cohort study with internet-based recruitment which intends to enroll 1,694 adult patients with COVID-19 diagnosis during the SARS-CoV-2 omicron wave in Brazil. Participants with confirmed symptomatic COVID-19 after january 2022 will be evaluated in order to assess incidence, potential risk factors and impact of post COVID-19 condition according to the WHO definition on health-related quality of life and other relevant patient-centered outcomes.

Enrollment: 1,694 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age ≥ 18 years;
• Brazilian resident;
• Symptomatica COVID-19 confirmed by reverse transcriptase polymerase chain reaction (RT-PCR) or antigen test for SARS-COV-2 after January 2022, with diagnosis at least 90 days before recruitment.

Exclusion criteria

• No availability to participate in remote research appointments;
• Communication difficulty (aphasia, important hearing loss, non-portuguese speaker, severe dementia)
• Refuse to provide informed consent

Trial design

1,694 participants in 1 patient group

Individuals with COVID-19 diagnosis during the SARS-CoV-2 omicron wave in Brazil

Treatment:

Other: Multiple exposures